Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Clearmind Medicine Inc
(NQ:
CMND
)
3.830
-0.310 (-7.49%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 4, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,176,890
Open
4.140
Bid (Size)
3.850 (3)
Ask (Size)
3.900 (1)
Prev. Close
4.140
Today's Range
3.500 - 4.720
52wk Range
0.1000 - 6.480
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial
December 01, 2023
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 30, 2023
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.
Via
Benzinga
Performance
YTD
+22.36%
+22.36%
1 Month
+2655.40%
+2655.40%
3 Month
+753.01%
+753.01%
6 Month
+572.05%
+572.05%
1 Year
+3.51%
+3.51%
More News
Read More
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
November 30, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 30, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 29, 2023
Via
InvestorPlace
Why Clearmind Medicine Stock Is Moving Today
November 28, 2023
Via
Benzinga
Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based Treatment
November 28, 2023
From
Clearmind Medicine Inc.
Via
GlobeNewswire
EXCLUSIVE: Clearmind Medicine's Psychedelic-Based Treatment Shows Encouraging Preclinical Activity In Obesity, Metabolic Disorders
November 28, 2023
Via
Benzinga
Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures
November 27, 2023
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
November 27, 2023
Via
Benzinga
Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice
November 21, 2023
Via
Benzinga
Clearmind Medicine Announces 1-for-30 Reverse Share Split
November 21, 2023
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance
November 17, 2023
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Announces Shareholders Meeting Results
November 15, 2023
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine to Pioneer Psychedelic Clinical Trials for Alcohol Use Disorder with Ivy League Universities
November 09, 2023
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 12, 2023
Via
Benzinga
Why BSQUARE Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
October 12, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 12, 2023
Via
InvestorPlace
Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th
October 05, 2023
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 11, 2023
Via
Benzinga
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $2.25 Million Public Offering for Clearmind Medicine Inc. (NASDAQ:CMND)
September 19, 2023
Via
ACCESSWIRE
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
September 20, 2023
Via
FinancialNewsMedia
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
September 18, 2023
Via
Benzinga
Exposures
Product Safety
Clearmind Medicine Closes US$2.25 Million Public Offering
September 18, 2023
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Psychedelics Capital Moves: Beckley Waves Raises $3.3M, Clearmind's $2.25M Public Offering
September 15, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.